title: Combination of Pim kinase inhibitors and Bcl-2 antagonists in chronic lymphocytic leukemia cells.
abstract: The Pim proteins are Ser/Thr kinases over-expressed in several hematological malignancies such as chronic lymphocytic leukemia (CLL) and some solid cancers like prostate cancer. Several small molecules have been developed to inhibit these kinases. In prostate cancer cell lines, the Pim kinase inhibitor SMI-4a and the Bcl-2 antagonist ABT-737 resulted in synergistic cytotoxicity. Akin to prostate cancer cells, CLL lymphocytes over-express Pim and Bcl-2 proteins. It was hypothesized that similar cytotoxic interaction should be observed in CLL. This study evaluated the in vitro cytotoxic effect of three Pim kinase inhibitors (AZD1208, SGI-1776 and SMI-4a) combined with Bcl-2 antagonists (ABT-737 or ABT-199) in malignant CLL lymphocytes. Data indicated Pim kinase inhibitors in combination with ABT-737 or ABT-199 resulted mostly in additive cytotoxicity with a few synergistic responses; however, the extent of synergism was less robust than that observed previously in prostate cancer cell lines treated with SMI-4a and ABT-737.
authors.affiliation: a Department of Experimental Therapeutics , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
authors.forename: Fabiola
authors.initials: F
authors.lastname: Cervantes-Gomez
authors.affiliation: a Department of Experimental Therapeutics , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
authors.forename: Bethany
authors.initials: B
authors.lastname: Lavergne
authors.affiliation: b Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Keating
authors.affiliation: b Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
authors.forename: William G
authors.initials: WG
authors.lastname: Wierda
authors.affiliation: a Department of Experimental Therapeutics , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.|b Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
authors.forename: Varsha
authors.initials: V
authors.lastname: Gandhi
keywords: ABT-199; AZD1208; CLL; Pim kinase; SGI-1776; SMI-4a